APO Research, Inc.

Biomimetic Cryoprotectants Industry Research Report 2026

Choose your research edition.

Compare the research focus and single-user price for each edition.
Research editionIndustry ResearchSelectedIndustry Growth & TrendsMarket StructureMarket Outlook & Growth OpportunitiesMarket Analysis & Forecast
Core differenceUnderstand the overall industry landscape, competition and leading companies.Examine growth drivers and how demand is developing across regional markets.Compare how the market is divided across companies, types and applications.Compare regional and country-level demand to assess geographic market opportunities.Assess market size, historical trends and forecasts for forward planning.
Single-user price$2,950 USD$3,450 USD$3,950 USD$4,250 USD$4,950 USD
Your choiceCurrent editionView editionView editionView editionView edition
View pricing & licenses

Biomimetic cryoprotectants are specialized chemical formulations that regulate ice nucleation, crystal growth, morphology, and recrystallization during the freezing, cryogenic storage, and thawing of living cells and biological tissues. Their active components reproduce selected ice regulating functions of natural antifreeze proteins and other cold adapted biological systems through molecular structures engineered to interact with ice surfaces and the surrounding aqueous phase. Commercially relevant materials include synthetic antifreeze peptoids, ice recrystallization inhibiting small molecules, modified polyvinyl alcohol, amphiphilic polymers, and polyampholytes such as carboxylated polylysine. Depending on molecular chemistry and formulation, these compounds modify ice nucleation behavior, inhibit crystal growth, restrict recrystallization during thermal fluctuations and warming, or suppress residual ice formation in vitrification systems. Their interactions at the ice and water interface can limit mechanical injury to cellular membranes, reduce damage associated with extracellular ice growth and osmotic stress, and preserve cellular integrity and functional recovery after thawing. Commercial products are supplied primarily as ready to use aqueous cryopreservation media and concentrated cryoprotectant additives, incorporating ice regulating molecules with selected buffers, electrolytes, sugars, polyols, and other formulation components. Certain formulations eliminate dimethyl sulfoxide (DMSO), serum, and animal derived proteins, while others combine biomimetic ice control agents with conventional permeating cryoprotectants to address complementary mechanisms of freezing injury. The defining technical characteristic is the demonstrated ice regulating function of the active formulation, which distinguishes these products from conventional preservation solutions relying exclusively on freezing point depression, osmotic adjustment, or increased solution viscosity. Commercial applications include cryopreservation of hematopoietic stem cells, mesenchymal stem cells, induced pluripotent stem cells, immune cells, engineered cellular therapeutics, reproductive cells, embryos, and biological specimens maintained in research and biobanking operations. Additional applications involve reproductive medicine, livestock breeding, tissue engineering, and experimental preservation of complex tissues and organs. Clinical cell manufacturing and laboratory biobanking constitute established commercial use environments, while whole organ cryopreservation remains at an earlier stage of technical development and commercialization.

Product & engineering

Understand the product.

Biomimetic cryoprotectants are specialized chemical formulations that regulate ice nucleation, crystal growth, morphology, and recrystallization during the freezing, cryogenic storage, and thawing of living cells and biological tissues. Their active components reproduce selected ice regulating functions of natural antifreeze proteins and other cold adapted biological systems through molecular structures engineered to interact with ice surfaces and the surrounding aqueous phase. Commercially relevant materials include synthetic antifreeze peptoids, ice recrystallization inhibiting small molecules, modified polyvinyl alcohol, amphiphilic polymers, and polyampholytes such as carboxylated polylysine. Depending on molecular chemistry and formulation, these compounds modify ice nucleation behavior, inhibit crystal growth, restrict recrystallization during thermal fluctuations and warming, or suppress residual ice formation in vitrification systems. Their interactions at the ice and water interface can limit mechanical injury to cellular membranes, reduce damage associated with extracellular ice growth and osmotic stress, and preserve cellular integrity and functional recovery after thawing. Commercial products are supplied primarily as ready to use aqueous cryopreservation media and concentrated cryoprotectant additives, incorporating ice regulating molecules with selected buffers, electrolytes, sugars, polyols, and other formulation components. Certain formulations eliminate dimethyl sulfoxide (DMSO), serum, and animal derived proteins, while others combine biomimetic ice control agents with conventional permeating cryoprotectants to address complementary mechanisms of freezing injury. The defining technical characteristic is the demonstrated ice regulating function of the active formulation, which distinguishes these products from conventional preservation solutions relying exclusively on freezing point depression, osmotic adjustment, or increased solution viscosity. Commercial applications include cryopreservation of hematopoietic stem cells, mesenchymal stem cells, induced pluripotent stem cells, immune cells, engineered cellular therapeutics, reproductive cells, embryos, and biological specimens maintained in research and biobanking operations. Additional applications involve reproductive medicine, livestock breeding, tissue engineering, and experimental preservation of complex tissues and organs. Clinical cell manufacturing and laboratory biobanking constitute established commercial use environments, while whole organ cryopreservation remains at an earlier stage of technical development and commercialization.

Selected research

Industry Research

Biomimetic Cryoprotectants Industry Research Report 2026

MARKET AT A GLANCE

Scale & outlook

2026
4.58USD million
2032
15.2USD million
Market size · USD million
010202025 · Approx. 3.46 USD million≈ 3.4620252026 · 4.58 USD million4.5820262032 · 15.2 USD million15.22032

Select a bar to inspect its value.

Source: APO Research, Inc.

Market perspective

According to APO Research, Inc, the global biomimetic cryoprotectants market was valued at approximately USD 3.46 million in 2025 and is projected to reach USD 4.58 million in 2026 and USD 15.2 million by 2032, representing a compound annual growth rate of 22.13% from 2026 to 2032. Market expansion is primarily associated with the commercial adoption of ice regulating cryopreservation formulations in cell therapy manufacturing, stem cell banking, immune cell processing, and biological sample preservation. Unlike conventional formulations dependent primarily on permeating cryoprotectants, biomimetic systems employ synthetic ice regulating molecules to control crystal growth and recrystallization during freezing and warming. Commercial sales comprise formulated cryopreservation media and separately supplied ice inhibiting additives. Consumption depends on the number of manufacturing and banking batches, preservation volume per batch, and frequency of freezing operations. Revenue is influenced by formulation complexity, the concentration of specialized active ingredients, manufacturing requirements, and the proportion of qualified products supplied for clinical manufacturing applications.

The United States and China are important centers of commercial product development and manufacturing. X-Therma received FDA acceptance of a Drug Master File for its XT-Thrive cryopreservation medium in April 2024 and announced GMP commercial readiness at its Hercules, California, manufacturing facility in May 2024. The company's synthetic peptoid technology enables chemically defined formulations without DMSO, serum, or proteins, addressing the processing and formulation requirements of cell therapy developers. In China, CellStore Biotechnology operates manufacturing facilities in Beijing and Dongguan, including a reported 1,000 m² GMP manufacturing workshop. Its ice controlling formulations cover stem cells, immune cells, and biological specimens. The CS-AT-D2 immune cell medium combines 10% DMSO with ice controlling materials, illustrating the continued commercial relevance of formulations that integrate conventional cryoprotectants with molecular ice regulation. Product selection depends on cell type, functional recovery after thawing, manufacturing compatibility, and the qualification requirements of individual customers.

Industry commercialization remains dependent on product specific development and customer adoption. BioLife Solutions acquired PanTHERA CryoSolutions in April 2025, gaining access to KryoAegis ice recrystallization inhibitor technology introduced in March 2024. Repligen completed its acquisition of BioLife Solutions in October 2026, expanding the commercial resources available to the combined biopreservation business. PanTHERA's second generation ice recrystallization inhibitor technology remained under development in 2026, with commercial contribution dependent on subsequent qualification and adoption. In Japan, BMG supplies StemCell Keep for research applications involving embryonic and induced pluripotent stem cells, reflecting the established but relatively specialized demand for advanced vitrification formulations. Through 2032, incremental market revenue is expected to arise principally from increased cell manufacturing activity, repeated purchases of qualified cryopreservation media, and broader adoption of specialized formulations in research and biobanking. Clinical process validation, formulation costs, and established DMSO based alternatives will continue to constrain the pace of substitution. Complex tissue and whole organ cryopreservation are expected to remain smaller commercial applications during the forecast period.

Full market overview

Report Scope

This report quantifies the global Biomimetic Cryoprotectants market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Biomimetic Cryoprotectants Market by Company

  • CellStore Biotechnology
  • X-Therma
  • Repligen
  • BMG
  • 21st Century Medicine

Biomimetic Cryoprotectants Segment by Type

  • Cryopreservation Media
  • Cryoprotectant Additives

Biomimetic Cryoprotectants Segment by Application

  • Cell Therapy
  • Research & Biobanking
  • Assisted Reproduction
  • Tissue & Organ Preservation
  • Livestock Breeding

Biomimetic Cryoprotectants Segment by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Spain
    • Netherlands
    • Switzerland
    • Sweden
    • Poland
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Southeast Asia
  • South America
    • Brazil
    • Argentina
    • Chile
    • Colombia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Türkiye
    • GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

  1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomimetic Cryoprotectants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  2. This report will help stakeholders to understand the global industry status and trends of Biomimetic Cryoprotectants and provides them with information on key market drivers, restraints, challenges, and opportunities.
  3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  4. This report stays updated with novel technology integration, features, and the latest developments in the market
  5. This report helps stakeholders to gain insights into which regions to target globally
  6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomimetic Cryoprotectants.
  7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

  1. Chapter 1: Research objectives, research methods, data sources, data cross-validation;
  2. Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  3. Chapter 3: Detailed analysis of Biomimetic Cryoprotectants manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  4. Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  5. Chapter 5: Production/output, value of Biomimetic Cryoprotectants by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  6. Chapter 6: Consumption of Biomimetic Cryoprotectants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  7. Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  8. Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  9. Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
  10. Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  11. Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures

List of Tables

  • Table 1. Secondary Sources
  • Table 2. Primary Sources
  • Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  • Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  • Table 5. Global Biomimetic Cryoprotectants Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
  • Table 6. Global Biomimetic Cryoprotectants Sales (L) of Manufacturers (2021-2026)
  • Table 7. Global Biomimetic Cryoprotectants Sales Market Share by Manufacturers (2021-2026)
  • Table 8. Global Biomimetic Cryoprotectants Revenue of Manufacturers (2021-2026)
  • Table 9. Global Biomimetic Cryoprotectants Revenue Share by Manufacturers (2021-2026)
  • Table 10. Global Market Biomimetic Cryoprotectants Average Price (USD/L) of Manufacturers (2021-2026)
  • Table 11. Global Biomimetic Cryoprotectants Industry Ranking, 2024 VS 2025 VS 2026
  • Table 12. Global Manufacturers of Biomimetic Cryoprotectants, Manufacturing Sites & Headquarters
  • Table 13. Global Manufacturers of Biomimetic Cryoprotectants, Product Type & Application
  • Table 14. Global Biomimetic Cryoprotectants Manufacturers Established Date
  • Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 16. Global Biomimetic Cryoprotectants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
  • Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
  • Table 18. CellStore Biotechnology Company Information
  • Table 19. CellStore Biotechnology Business Overview
  • Table 20. CellStore Biotechnology Biomimetic Cryoprotectants Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 21. CellStore Biotechnology Biomimetic Cryoprotectants Product Portfolio
  • Table 22. CellStore Biotechnology Recent Developments
  • Table 23. X-Therma Company Information
  • Table 24. X-Therma Business Overview
  • Table 25. X-Therma Biomimetic Cryoprotectants Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 26. X-Therma Biomimetic Cryoprotectants Product Portfolio
  • Table 27. X-Therma Recent Developments
  • Table 28. Repligen Company Information
  • Table 29. Repligen Business Overview
  • Table 30. Repligen Biomimetic Cryoprotectants Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 31. Repligen Biomimetic Cryoprotectants Product Portfolio
  • Table 32. Repligen Recent Developments
  • Table 33. BMG Company Information
  • Table 34. BMG Business Overview
  • Table 35. BMG Biomimetic Cryoprotectants Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 36. BMG Biomimetic Cryoprotectants Product Portfolio
  • Table 37. BMG Recent Developments
  • Table 38. 21st Century Medicine Company Information
  • Table 39. 21st Century Medicine Business Overview
  • Table 40. 21st Century Medicine Biomimetic Cryoprotectants Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 41. 21st Century Medicine Biomimetic Cryoprotectants Product Portfolio
  • Table 42. 21st Century Medicine Recent Developments
  • Table 43. Global Biomimetic Cryoprotectants Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
  • Table 44. Global Biomimetic Cryoprotectants Sales by Region (2021-2026) & (L)
  • Table 45. Global Biomimetic Cryoprotectants Sales Market Share by Region (2021-2026)
  • Table 46. Global Biomimetic Cryoprotectants Sales by Region (2027-2032) & (L)
  • Table 47. Global Biomimetic Cryoprotectants Sales Market Share by Region (2027-2032)
  • Table 48. Global Biomimetic Cryoprotectants Revenue by Region (2021-2026) & (US$ Million)
  • Table 49. Global Biomimetic Cryoprotectants Revenue Market Share by Region (2021-2026)
  • Table 50. Global Biomimetic Cryoprotectants Revenue by Region (2027-2032) & (US$ Million)
  • Table 51. Global Biomimetic Cryoprotectants Revenue Market Share by Region (2027-2032)
  • Table 52. North America Biomimetic Cryoprotectants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 53. North America Biomimetic Cryoprotectants Sales by Country (2021-2026) & (L)
  • Table 54. North America Biomimetic Cryoprotectants Sales by Country (2027-2032) & (L)
  • Table 55. North America Biomimetic Cryoprotectants Revenue by Country (2021-2026) & (US$ Million)
  • Table 56. North America Biomimetic Cryoprotectants Revenue by Country (2027-2032) & (US$ Million)
  • Table 57. Europe Biomimetic Cryoprotectants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 58. Europe Biomimetic Cryoprotectants Sales by Country (2021-2026) & (L)
  • Table 59. Europe Biomimetic Cryoprotectants Sales by Country (2027-2032) & (L)
  • Table 60. Europe Biomimetic Cryoprotectants Revenue by Country (2021-2026) & (US$ Million)
  • Table 61. Europe Biomimetic Cryoprotectants Revenue by Country (2027-2032) & (US$ Million)
  • Table 62. Asia Pacific Biomimetic Cryoprotectants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 63. Asia Pacific Biomimetic Cryoprotectants Sales by Country (2021-2026) & (L)
  • Table 64. Asia Pacific Biomimetic Cryoprotectants Sales by Country (2027-2032) & (L)
  • Table 65. Asia Pacific Biomimetic Cryoprotectants Revenue by Country (2021-2026) & (US$ Million)
  • Table 66. Asia Pacific Biomimetic Cryoprotectants Revenue by Country (2027-2032) & (US$ Million)
  • Table 67. South America Biomimetic Cryoprotectants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 68. South America Biomimetic Cryoprotectants Sales by Country (2021-2026) & (L)
  • Table 69. South America Biomimetic Cryoprotectants Sales by Country (2027-2032) & (L)
  • Table 70. South America Biomimetic Cryoprotectants Revenue by Country (2021-2026) & (US$ Million)
  • Table 71. South America Biomimetic Cryoprotectants Revenue by Country (2027-2032) & (US$ Million)
  • Table 72. Middle East and Africa Biomimetic Cryoprotectants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 73. Middle East and Africa Biomimetic Cryoprotectants Sales by Country (2021-2026) & (L)
  • Table 74. Middle East and Africa Biomimetic Cryoprotectants Sales by Country (2027-2032) & (L)
  • Table 75. Middle East and Africa Biomimetic Cryoprotectants Revenue by Country (2021-2026) & (US$ Million)
  • Table 76. Middle East and Africa Biomimetic Cryoprotectants Revenue by Country (2027-2032) & (US$ Million)
  • Table 77. Global Biomimetic Cryoprotectants Sales by Type (2021-2026) & (L)
  • Table 78. Global Biomimetic Cryoprotectants Sales by Type (2027-2032) & (L)
  • Table 79. Global Biomimetic Cryoprotectants Sales Market Share by Type (2021-2026)
  • Table 80. Global Biomimetic Cryoprotectants Sales Market Share by Type (2027-2032)
  • Table 81. Global Biomimetic Cryoprotectants Revenue by Type (2021-2026) & (US$ Million)
  • Table 82. Global Biomimetic Cryoprotectants Revenue by Type (2027-2032) & (US$ Million)
  • Table 83. Global Biomimetic Cryoprotectants Revenue Market Share by Type (2021-2026)
  • Table 84. Global Biomimetic Cryoprotectants Revenue Market Share by Type (2027-2032)
  • Table 85. Global Biomimetic Cryoprotectants Price by Type (2021-2026) & (USD/L)
  • Table 86. Global Biomimetic Cryoprotectants Price by Type (2027-2032) & (USD/L)
  • Table 87. Global Biomimetic Cryoprotectants Sales by Application (2021-2026) & (L)
  • Table 88. Global Biomimetic Cryoprotectants Sales by Application (2027-2032) & (L)
  • Table 89. Global Biomimetic Cryoprotectants Sales Market Share by Application (2021-2026)
  • Table 90. Global Biomimetic Cryoprotectants Sales Market Share by Application (2027-2032)
  • Table 91. Global Biomimetic Cryoprotectants Revenue by Application (2021-2026) & (US$ Million)
  • Table 92. Global Biomimetic Cryoprotectants Revenue by Application (2027-2032) & (US$ Million)
  • Table 93. Global Biomimetic Cryoprotectants Revenue Market Share by Application (2021-2026)
  • Table 94. Global Biomimetic Cryoprotectants Revenue Market Share by Application (2027-2032)
  • Table 95. Global Biomimetic Cryoprotectants Price by Application (2021-2026) & (USD/L)
  • Table 96. Global Biomimetic Cryoprotectants Price by Application (2027-2032) & (USD/L)
  • Table 97. Key Raw Materials
  • Table 98. Raw Materials Key Suppliers
  • Table 99. Biomimetic Cryoprotectants Distributors List
  • Table 100. Biomimetic Cryoprotectants Customers List
  • Table 101. Biomimetic Cryoprotectants Industry Trends
  • Table 102. Biomimetic Cryoprotectants Industry Drivers
  • Table 103. Biomimetic Cryoprotectants Industry Restraints
  • Table 104. Authors List of This Report

List of Figures

  • Figure 1. Research Methodology
  • Figure 2. Research Process
  • Figure 3. Key Executives Interviewed
  • Figure 4. Biomimetic Cryoprotectants Product Image
  • Figure 5. Global Biomimetic Cryoprotectants Revenue (US$ Million), 2021 VS 2025 VS 2032
  • Figure 6. Global Biomimetic Cryoprotectants Market Size (2021-2032) & (US$ Million)
  • Figure 7. Global Biomimetic Cryoprotectants Sales (2021-2032) & (L)
  • Figure 8. Global Biomimetic Cryoprotectants Average Price (USD/L) & (2021-2032)
  • Figure 9. Cryopreservation Media Product Image
  • Figure 10. Cryoprotectant Additives Product Image
  • Figure 11. Cell Therapy Product Image
  • Figure 12. Research & Biobanking Product Image
  • Figure 13. Assisted Reproduction Product Image
  • Figure 14. Tissue & Organ Preservation Product Image
  • Figure 15. Livestock Breeding Product Image
  • Figure 16. Global Biomimetic Cryoprotectants Revenue Share by Manufacturers in 2025
  • Figure 17. Global Manufacturers of Biomimetic Cryoprotectants, Manufacturing Sites & Headquarters
  • Figure 18. Global Top 5 and 10 Biomimetic Cryoprotectants Players Market Share by Revenue in 2025
  • Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
  • Figure 20. Global Biomimetic Cryoprotectants Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
  • Figure 21. Global Biomimetic Cryoprotectants Sales by Region in 2025
  • Figure 22. Global Biomimetic Cryoprotectants Revenue by Region in 2025
  • Figure 23. North America Biomimetic Cryoprotectants Market Size by Country in 2025
  • Figure 24. North America Biomimetic Cryoprotectants Sales Market Share by Country (2021-2032)
  • Figure 25. North America Biomimetic Cryoprotectants Revenue Market Share by Country (2021-2032)
  • Figure 26. United States Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 27. Canada Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 28. Mexico Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 29. Europe Biomimetic Cryoprotectants Market Size by Country in 2025
  • Figure 30. Europe Biomimetic Cryoprotectants Sales Market Share by Country (2021-2032)
  • Figure 31. Europe Biomimetic Cryoprotectants Revenue Market Share by Country (2021-2032)
  • Figure 32. Germany Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 33. France Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 34. U.K. Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 35. Italy Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 36. Russia Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 37. Spain Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 38. Netherlands Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 39. Switzerland Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 40. Sweden Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 41. Poland Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 42. Asia Pacific Biomimetic Cryoprotectants Market Size by Country in 2025
  • Figure 43. Asia Pacific Biomimetic Cryoprotectants Sales Market Share by Country (2021-2032)
  • Figure 44. Asia Pacific Biomimetic Cryoprotectants Revenue Market Share by Country (2021-2032)
  • Figure 45. China Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 46. Japan Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 47. South Korea Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 48. India Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 49. Australia Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 50. Taiwan Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 51. Southeast Asia Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 52. Southeast Asia Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 53. South America Biomimetic Cryoprotectants Market Size by Country in 2025
  • Figure 54. South America Biomimetic Cryoprotectants Sales Market Share by Country (2021-2032)
  • Figure 55. South America Biomimetic Cryoprotectants Revenue Market Share by Country (2021-2032)
  • Figure 56. Brazil Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 57. Argentina Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 58. Chile Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 59. Colombia Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 60. Middle East and Africa Biomimetic Cryoprotectants Market Size by Country in 2025
  • Figure 61. Middle East and Africa Biomimetic Cryoprotectants Sales Market Share by Country (2021-2032)
  • Figure 62. Middle East and Africa Biomimetic Cryoprotectants Revenue Market Share by Country (2021-2032)
  • Figure 63. Egypt Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 64. South Africa Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 65. Israel Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 66. Türkiye Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 67. GCC Countries Biomimetic Cryoprotectants Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 68. Global Biomimetic Cryoprotectants Sales Market Share by Type (2021-2032)
  • Figure 69. Global Biomimetic Cryoprotectants Revenue Market Share by Type (2021-2032)
  • Figure 70. Global Biomimetic Cryoprotectants Price (USD/L) by Type (2021-2032)
  • Figure 71. Global Biomimetic Cryoprotectants Sales Market Share by Application (2021-2032)
  • Figure 72. Global Biomimetic Cryoprotectants Revenue Market Share by Application (2021-2032)
  • Figure 73. Global Biomimetic Cryoprotectants Price (USD/L) by Application (2021-2032)
  • Figure 74. Biomimetic Cryoprotectants Value Chain
  • Figure 75. Biomimetic Cryoprotectants Production Mode & Process
  • Figure 76. Direct Comparison with Distribution Share
  • Figure 77. Distributors Profiles
  • Figure 78. Biomimetic Cryoprotectants Industry Opportunities and Challenges

Scope & coverage.

By Type
  • Cryopreservation Media
  • Cryoprotectant Additives
By Application
  • Cell Therapy
  • Research & Biobanking
  • Assisted Reproduction
  • Tissue & Organ Preservation
  • Livestock Breeding
Companies covered
  • CellStore Biotechnology
  • X-Therma
  • Repligen
  • BMG
  • 21st Century Medicine

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Biomimetic Cryoprotectants Market Size (2021-2032)
  4. 2.2.2 Global Biomimetic Cryoprotectants Sales (2021-2032)
  5. 2.2.3 Global Biomimetic Cryoprotectants Market Average Price (2021-2032)
  6. 2.3 Biomimetic Cryoprotectants by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Cryopreservation Media
  9. 2.3.3 Cryoprotectant Additives
  10. 2.4 Biomimetic Cryoprotectants by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Cell Therapy
  13. 2.4.3 Research & Biobanking
  14. 2.4.4 Assisted Reproduction
  15. 2.4.5 Tissue & Organ Preservation
  16. 2.4.6 Livestock Breeding
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Biomimetic Cryoprotectants Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Biomimetic Cryoprotectants Sales (L) of Manufacturers (2021-2026)
  3. 3.3 Global Biomimetic Cryoprotectants Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Biomimetic Cryoprotectants Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Biomimetic Cryoprotectants Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Biomimetic Cryoprotectants, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Biomimetic Cryoprotectants, Product Type & Application
  8. 3.8 Global Manufacturers of Biomimetic Cryoprotectants, Established Date
  9. 3.9 Global Biomimetic Cryoprotectants Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CellStore Biotechnology
  2. 4.1.1 CellStore Biotechnology Company Information
  3. 4.1.2 CellStore Biotechnology Business Overview
  4. 4.1.3 CellStore Biotechnology Biomimetic Cryoprotectants Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 CellStore Biotechnology Biomimetic Cryoprotectants Product Portfolio
  6. 4.1.5 CellStore Biotechnology Recent Developments
  7. 4.2 X-Therma
  8. 4.2.1 X-Therma Company Information
  9. 4.2.2 X-Therma Business Overview
  10. 4.2.3 X-Therma Biomimetic Cryoprotectants Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 X-Therma Biomimetic Cryoprotectants Product Portfolio
  12. 4.2.5 X-Therma Recent Developments
  13. 4.3 Repligen
  14. 4.3.1 Repligen Company Information
  15. 4.3.2 Repligen Business Overview
  16. 4.3.3 Repligen Biomimetic Cryoprotectants Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Repligen Biomimetic Cryoprotectants Product Portfolio
  18. 4.3.5 Repligen Recent Developments
  19. 4.4 BMG
  20. 4.4.1 BMG Company Information
  21. 4.4.2 BMG Business Overview
  22. 4.4.3 BMG Biomimetic Cryoprotectants Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 BMG Biomimetic Cryoprotectants Product Portfolio
  24. 4.4.5 BMG Recent Developments
  25. 4.5 21st Century Medicine
  26. 4.5.1 21st Century Medicine Company Information
  27. 4.5.2 21st Century Medicine Business Overview
  28. 4.5.3 21st Century Medicine Biomimetic Cryoprotectants Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 21st Century Medicine Biomimetic Cryoprotectants Product Portfolio
  30. 4.5.5 21st Century Medicine Recent Developments
5 Global Biomimetic Cryoprotectants Market Scenario by Region
  1. 5.1 Global Biomimetic Cryoprotectants Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Biomimetic Cryoprotectants Sales by Region: 2021-2032
  3. 5.2.1 Global Biomimetic Cryoprotectants Sales by Region: 2021-2026
  4. 5.2.2 Global Biomimetic Cryoprotectants Sales by Region: 2027-2032
  5. 5.3 Global Biomimetic Cryoprotectants Revenue by Region: 2021-2032
  6. 5.3.1 Global Biomimetic Cryoprotectants Revenue by Region: 2021-2026
  7. 5.3.2 Global Biomimetic Cryoprotectants Revenue by Region: 2027-2032
  8. 5.4 North America Biomimetic Cryoprotectants Market Facts & Figures by Country
  9. 5.4.1 North America Biomimetic Cryoprotectants Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Biomimetic Cryoprotectants Sales by Country (2021-2032)
  11. 5.4.3 North America Biomimetic Cryoprotectants Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Biomimetic Cryoprotectants Market Facts & Figures by Country
  16. 5.5.1 Europe Biomimetic Cryoprotectants Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Biomimetic Cryoprotectants Sales by Country (2021-2032)
  18. 5.5.3 Europe Biomimetic Cryoprotectants Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Biomimetic Cryoprotectants Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Biomimetic Cryoprotectants Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Biomimetic Cryoprotectants Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Biomimetic Cryoprotectants Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Biomimetic Cryoprotectants Market Facts & Figures by Country
  41. 5.7.1 South America Biomimetic Cryoprotectants Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Biomimetic Cryoprotectants Sales by Country (2021-2032)
  43. 5.7.3 South America Biomimetic Cryoprotectants Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Biomimetic Cryoprotectants Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Biomimetic Cryoprotectants Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Biomimetic Cryoprotectants Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Biomimetic Cryoprotectants Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Biomimetic Cryoprotectants Sales by Type (2021-2032)
  2. 6.1.1 Global Biomimetic Cryoprotectants Sales by Type (2021-2032) & (L)
  3. 6.1.2 Global Biomimetic Cryoprotectants Sales Market Share by Type (2021-2032)
  4. 6.2 Global Biomimetic Cryoprotectants Revenue by Type (2021-2032)
  5. 6.2.1 Global Biomimetic Cryoprotectants Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Biomimetic Cryoprotectants Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Biomimetic Cryoprotectants Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Biomimetic Cryoprotectants Sales by Application (2021-2032)
  2. 7.1.1 Global Biomimetic Cryoprotectants Sales by Application (2021-2032) & (L)
  3. 7.1.2 Global Biomimetic Cryoprotectants Sales Market Share by Application (2021-2032)
  4. 7.2 Global Biomimetic Cryoprotectants Revenue by Application (2021-2032)
  5. 7.2.1 Global Biomimetic Cryoprotectants Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Biomimetic Cryoprotectants Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Biomimetic Cryoprotectants Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Biomimetic Cryoprotectants Value Chain Analysis
  2. 8.1.1 Biomimetic Cryoprotectants Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Biomimetic Cryoprotectants Production Mode & Process
  5. 8.2 Biomimetic Cryoprotectants Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Biomimetic Cryoprotectants Distributors
  8. 8.2.3 Biomimetic Cryoprotectants Customers
9 Global Biomimetic Cryoprotectants Analyzing Market Dynamics
  1. 9.1 Biomimetic Cryoprotectants Industry Trends
  2. 9.2 Biomimetic Cryoprotectants Industry Drivers
  3. 9.3 Biomimetic Cryoprotectants Industry Opportunities and Challenges
  4. 9.4 Biomimetic Cryoprotectants Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.